Does Oscar Health Cover Wegovy?
The verdict
Conditional on most plans
Oscar Health, which operates primarily in the ACA individual and small-group markets, generally excludes Wegovy for weight loss on its plans; drug-level formulary specifics are not publicly published in detail. Readers should verify coverage on Oscar's drug-lookup tool for their specific plan.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Oscar Health using your member ID.
Key facts
ACA individual-market plans generally exclude weight-loss drugs as a benefit, making Wegovy weight-loss coverage uncommon on Oscar's core product line regardless of prior-authorization submission.
KFF, Anti-Obesity Medication Coverage in the ACA Marketplace
Oscar Health does not publish a comprehensive drug-level formulary for Wegovy publicly; coverage verification requires the Oscar drug-lookup tool or member services for the specific plan.
Oscar Health member resources, hioscar.com
The NovoCare Wegovy Savings Offer (as little as $25 per month) is available to ACA exchange plan members whose plan covers Wegovy — ACA plans are not classified as government programs for this offer.
NovoCare, Wegovy Savings Offer eligibility terms
Medicare vs. commercial coverage
Whether Oscar Health covers Wegovy depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Oscar has minimal Medicare presence. Where applicable, Medicare Part D follows the federal statutory exclusion for weight-loss drugs — Wegovy cannot be covered for weight loss under any Medicare plan. The cardiovascular risk reduction indication may be coverable with prior authorization for members with established CVD who are overweight or obese. The Medicare GLP-1 Bridge ($50 per month from July 1, 2026) provides weight-loss access outside Part D for eligible beneficiaries. Oscar's Medicare footprint is small; verify any Oscar Medicare plan specifics with Oscar member services.
Commercial / Employer
Group & marketplace plans
Oscar operates primarily in the ACA individual and small-group markets. ACA individual plans generally exclude weight-loss GLP-1s as an anti-obesity drug benefit — this is the default ACA market outcome, not a published Oscar formulary decision. For small-group commercial plans, coverage is employer-dependent; weight-loss Wegovy is included only where the group employer purchased the anti-obesity benefit. Per-plan drug-level formulary detail is not publicly published by Oscar in a comprehensive drug-level document; readers must verify via Oscar's drug-lookup tool or member services. Where any Oscar plan covers Wegovy, prior authorization is expected. One important nuance: if an Oscar ACA exchange plan does cover Wegovy, the NovoCare Wegovy Savings Offer (as little as $25 per month, max $100 per 28-day supply) is available because ACA exchange plans are not treated as government programs for this program. Oscar also has limited Medicaid managed-care presence; state Medicaid obesity coverage applies.
The 4 boxes you must tick to get approved
Commercial plans that will consider Wegovy require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Wegovy actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
$1,349 per month (Novo Nordisk published list price for a 28-day supply)
List price with no coverage — before any manufacturer savings card.
With coverage
Plan-specific cost-share not publicly published. NovoCare Wegovy Savings Offer: if an Oscar plan covers Wegovy, commercially or ACA-insured members may pay as little as $25 per month (max $100 savings per 28-day supply) — ACA exchange plans are not government programs for this offer. NovoCare self-pay approximately $349 per month for standard injection doses where no coverage exists.
Typical monthly copay once prior authorization is approved.
Bridge program
From January 1, 2027, Novo Nordisk has announced a list-price reduction to approximately $675 per month; the IRA-negotiated Maximum Fair Price of $274 per 30-day supply takes effect for Medicare January 1, 2027.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Actual cost-share varies by Oscar plan tier and pharmacy. Verify on the Oscar drug-lookup tool for your specific plan.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use Oscar's drug-lookup tool for your specific plan
Log into the Oscar member portal or use the public drug-lookup tool at hioscar.com and search for Wegovy (semaglutide 2.4 mg). Formulary coverage, tier placement, and prior-authorization requirements vary by plan and are not published comprehensively at the drug level elsewhere.
- 2
For small-group plans, confirm with your employer HR
If you are on an Oscar small-group employer plan, ask your HR department whether anti-obesity medications are included in your benefit design. A benefit exclusion cannot be overridden by prior authorization — knowing this before submitting a PA saves time.
- 3
If covered, check NovoCare savings card eligibility
If your Oscar plan covers Wegovy, visit novocare.com to see if you qualify for the NovoCare Wegovy Savings Offer (as little as $25 per month). ACA exchange plans are eligible for this offer. Have your insurance information ready to confirm eligibility.
Options if Oscar Health won't cover Wegovy
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
NovoCare self-pay program
Novo Nordisk's NovoCare offers approximately $199 per month for starting Wegovy doses (0.25/0.5 mg) for first two fills through December 31, 2026, then approximately $349 per month for standard injection doses. Does not require insurance. Verify current pricing at novocare.com.
NovoCare savings card (if plan covers Wegovy)
If an Oscar ACA or commercial plan covers Wegovy, the NovoCare savings card can reduce cost-share to as little as $25 per month (max $100 savings per 28-day supply). ACA exchange plans are not treated as government programs for this offer — this is a genuinely useful nuance for Oscar's predominantly ACA readership.
Compounded semaglutide
Compounded semaglutide, available through licensed telehealth platforms, does not require insurance prior authorization. Starting from $49 per month. Compounded semaglutide is not the same medication as Wegovy and has not been approved by the FDA.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Oscar's ACA individual plans generally exclude weight-loss GLP-1s, including Wegovy, because the ACA individual market typically does not include anti-obesity drug benefits by default. Oscar does not publish comprehensive drug-level formulary detail publicly, so readers must verify their specific plan on the Oscar drug-lookup tool at hioscar.com. If an Oscar ACA plan does cover Wegovy, prior authorization is expected and the NovoCare savings card is available on ACA plans.
Oscar Health does not publish a comprehensive drug-level formulary document with Wegovy-specific tier and PA details in the same way some larger insurers do. Coverage varies by plan type, state, and employer. The most reliable way to verify Wegovy coverage on an Oscar plan is to search via the Oscar member portal or public drug-lookup tool, or to call Oscar member services with your member ID. This is a verify-with-plan situation, not a coverage guarantee.
If an Oscar plan covers Wegovy, yes — the NovoCare Wegovy Savings Offer (as little as $25 per month, max $100 per 28-day supply) is available to commercially insured and ACA exchange-insured patients whose plan covers the drug. ACA exchange plans are not treated as government programs for this offer. The savings card is not available to Medicare or Medicaid beneficiaries. Verify your eligibility at novocare.com.
Wegovy is FDA-approved for cardiovascular risk reduction in adults with established cardiovascular disease who are overweight or obese. Where Oscar covers Wegovy (generally on plans that include an anti-obesity or CV benefit), this indication may be covered with prior authorization. Oscar's drug-level PA criteria for the CV indication are not publicly published; verify on the plan drug-lookup tool or with Oscar member services.
Ozempic (semaglutide, lower doses) is FDA-approved for type 2 diabetes and is generally covered with prior authorization on commercial and ACA plans that include a diabetes benefit. Wegovy (semaglutide 2.4 mg) is for weight loss and CV risk reduction — the anti-obesity benefit is typically excluded on ACA individual plans. Same molecule, different drug, different coverage logic. Oscar members with type 2 diabetes seeking semaglutide should discuss Ozempic; those seeking weight management face the ACA exclusion reality.
Related Articles
Does Network Health Cover Wegovy? 2026 Coverage Guide | Curex
Network Health covers Wegovy only where your employer opted in. Medicare Advantage faces the Part D exclusion. Verify on Network Health's drug-lookup tool.
Read moreDoes BCBS of Arizona Cover Wegovy? 2026 Guide | Curex
BCBS of Arizona covers Wegovy only where your employer opted in; formulary not published. Verify via drug-lookup and confirm with HR first.
Read moreDoes Blue Cross Blue Shield Cover Wegovy? 2026 | Curex
BCBS is 33+ independent affiliates — no single Wegovy answer. Trend favors exclusion in 2025-2026. Find your affiliate and verify your formulary.
Read moreDoes Blue Cross Blue Shield of Illinois Cover Wegovy? | Curex
BCBS Illinois (HCSC) covers Wegovy only where your employer opts in. ACA plans exclude it. Formulary not public — verify on your plan's drug-lookup tool.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Priority Health Cover Wegovy? 2026 Guide | Curex
Priority Health Wegovy coverage is employer-dependent and not published. Michigan Medicaid covers it with PA. What Michigan members need to verify.
Read moreWhether or not Oscar Health covers Wegovy, there's a path that skips insurance
Oscar's ACA plans generally exclude Wegovy for weight loss. For patients who want semaglutide access without ACA-plan coverage, compounded semaglutide from $49/mo (compounded tirzepatide from $149/mo) is available at Curex — no insurance, no prior authorization. Compounded semaglutide is not the same medication as Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Wegovy and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Oscar Health before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Wegovy and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.